PayPal Holdings, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? PayPal Holdings, Inc. trades at $55.49 (market cap $49.27B), while State Street SPDR S&P Biotech ETF trades at $152.12. The key difference: PayPal Holdings, Inc. pays a 1% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, PayPal Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| PYPL | XBI | |
|---|---|---|
Market Cap | $49.27B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $78.22 | $164.28 |
52-Week Low | $39.08 | $85.16 |
Enterprise Value | $49.33B | — |
Dividend Yield | 1% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $150.94, down 2.14% today, with technical indicators showing a bearish trend but oversold RSI suggesting potential near-term support. The ETF lacks traditional valuation metrics due to its structure, but recent news highlights strong biotech sector momentum, including a 17% monthly gain and robust M&A activity. Analyst coverage is limited to a single hold rating, reflecting cautious optimism amid sector volatility.
Outlook: Biotech sector tailwinds from M&A and AI-driven drug discovery offer upside, but high volatility and policy risks persist. Investors should weigh XBI's equal-weight exposure to small/mid-cap biotech against its elevated beta, with technical support near $149 critical for short-term direction.
Trailing returns across standard periods
Latest headlines on both assets
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →